BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE: Pharmaceutical manufacturers, suppliers, and distributors

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Bausch And Lomb	NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC	bacitracin zinc; neomycin sulfate; polymyxin b sulfate	OINTMENT;OPHTHALMIC	064064	ANDA	Bausch & Lomb Incorporated	24208-780-55	1 TUBE in 1 CARTON (24208-780-55) / 3.5 g in 1 TUBE	1995-10-30
Padagis Us	NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC	bacitracin zinc; neomycin sulfate; polymyxin b sulfate	OINTMENT;OPHTHALMIC	060764	ANDA	Padagis US LLC	0574-4250-35	1 TUBE in 1 CARTON (0574-4250-35) / 3.5 g in 1 TUBE	2015-01-05
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Last updated: July 29, 2025

Introduction

The pharmaceutical market for topical antibiotics, including Bacitracin Zinc, Neomycin Sulfate, and Polymyxin B Sulfate, is characterized by a diverse supply chain comprising global and regional suppliers. These antibiotics are critical in treating bacterial infections, especially in dermatology and wound management. Their manufacturing hinges on specialized chemical synthesis, fermentation processes, and stringent quality controls, which influence supplier positioning and market dynamics.

In this analysis, we examine leading suppliers for these antibiotics, their manufacturing capacities, regional dominance, regulatory statuses, and recent market developments. This comprehensive overview aids stakeholders in strategic sourcing, regulatory compliance, and market forecasting.

1. Bacitracin Zinc Suppliers

Overview & Market Trends

Bacitracin Zinc is a polypeptide antibiotic predominantly used in topical formulations. Its manufacturing relies on fermentation processes involving Bacillus subtilis. Global supply depends on a handful of key players capable of producing pharmaceutical-grade Bacitracin Zinc at high purity levels conforming to Good Manufacturing Practices (GMP).

Major Suppliers

a. Sandoz (Novartis)

Overview: As a major generic pharmaceutical manufacturer, Sandoz supplies Bacitracin Zinc through extensive formulations and active pharmaceutical ingredients (API) portfolios. Sandoz's global reach ensures broad distribution channels.
Capacity: Sandoz maintains large-scale fermentation facilities enhanced with advanced purification systems complying with regulatory standards.
Regions: Europe, North America, Asia-Pacific.

b. Zhejiang Hisun Pharmaceutical Co., Ltd.

Overview: Based in China, Hisun is a prominent producer of antibiotics, including Bacitracin Zinc. It offers both API and finished dosage forms.
Capacity: Significant fermentation capacity with localized supply in Asia and exports globally.
Regulatory Standing: Approved by the Chinese FDA, with some facilities attaining global regulatory recognition.

c. Zhejiang KaiZheng Pharmaceutical Co., Ltd.

Overview: Focuses on antibiotic production, including Bacitracin Zinc, with a focus on quality and affordability.
Capacity: Mid-size manufacturer with increasing capacities aligned with global export demands.

d. Other Notable Suppliers

Guangzhou Pharmaceutical Industry (China)
Sigma-Aldrich (Merck KGaA): Primarily a distributor sourcing from bulk manufacturers.

Supply Chain & Market Considerations

The Chinese market dominates Bacitracin Zinc production, often leading in cost-effective manufacturing. However, supply quality and consistency are critical, with global regulatory agencies scrutinizing manufacturing standards. The capacity for large-scale fermentation and purification remains pivotal in meeting global demand, especially amidst supply chain disruptions.

2. Neomycin Sulfate Suppliers

Overview & Market Trends

Neomycin Sulfate is an aminoglycoside antibiotic produced mainly via fermentation of Streptomyces fradiae. Its high demand in topical and ophthalmic applications makes it a staple in the antibiotic supply chain.

Major Suppliers

a. Hubei Huahao Pharmaceutical Co., Ltd.

Overview: A leading Chinese manufacturer specializing in fermentation-derived antibiotics, including Neomycin Sulfate.
Capacity: Large-scale fermentation with dedicated purification facilities.
Regulatory Status: Approved under Chinese standards; some exports adhere to GMP standards for international markets.

b. Zhejiang Medicine Co., Ltd.

Overview: Noted for producing a broad spectrum of antibiotics, including Neomycin Sulfate, with a focus on quality control.
Regions: Supplies primarily in Asia, with increasing penetration into Western markets.

c. Pfizer Inc. (Historical & Transition Markets)

Overview: Historically involved in production, but manufacturing has shifted or outsourced; suppliers now tend to be regional generic producers.

d. Other Key Players

Qingdao Sanmu Pharmaceutical Co., Ltd.
Shandong Luoxin Pharmaceutical Group

Supply Chain & Industry Dynamics

Manufacturing of Neomycin Sulfate relies on controlled fermentation processes. Asian manufacturers, particularly Chinese firms, dominate supply due to cost advantages. Quality assurance remains a critical factor, with regulatory agencies increasingly requiring comprehensive GMP compliance for export markets.

3. Polymyxin B Sulfate Suppliers

Overview & Market Trends

Polymyxin B Sulfate, a cyclic peptide antibiotic, is produced via fermentation of Paenibacillus polymyxa. It is mainly used as a topical agent and in combination therapies for multidrug-resistant bacterial infections.

Major Suppliers

a. Qilu Pharmaceutical Co., Ltd.

Overview: A prominent Chinese manufacturer with high-capacity fermentation facilities producing Polymyxin B.
Regulatory Standing: GMP-certified, with export licenses aligned with global standards.

b. Chengdu Institute of Biological Products

Overview: A government-backed entity specializing in fermentation-derived antibiotics.
Importance: Supplies domestically and exports active ingredients globally.

c. XiaoGao Pharma

Overview: Specializes in microbial fermentation products, including Polymyxin B, with expanding international presence.

d. Other Suppliers

Fresenius Kabi: Globally recognized, sourcing from verified manufacturers.
Hainan Zhongxin Pharmaceutical Co., Ltd.

Supply Chain & Market Considerations

The production of Polymyxin B is highly dependent on specialized microbial fermentation. Chinese companies currently dominate the market, supported by cost-effective manufacturing and increasing international certifications. The global shortage of Polymyxin B in recent years has driven supply diversification efforts.

Regulatory and Quality Aspects

The pharmaceutical supply chain's robustness hinges on adherence to GMP, GxP standards, and regional regulatory approvals. The US FDA, EMA, and other agencies increasingly scrutinize manufacturing sites, influencing supplier choices. Suppliers with comprehensive compliance certifications are preferable for international markets.

Recent Market Developments

Supply Chain Diversification: Growing interest in expanding suppliers beyond China to reduce dependency risk.
Regulatory Stringency: Increasing compliance demands prompting manufacturers to upgrade facilities.
Technological Innovations: Adoption of optimized fermentation processes and purification technologies to increase yields and purity levels.

Key Takeaways

The Chinese pharmaceutical industry leads in the production of Bacitracin Zinc, Neomycin Sulfate, and Polymyxin B Sulfate, primarily due to cost advantages and fermentation expertise.
Leading global suppliers like Sandoz and major Chinese manufacturers maintain extensive capacities, but supply chain resilience depends on strict quality assurance.
Regulatory compliance (GMP, GxP) is critical; suppliers with validated manufacturing processes are preferred.
Strategic sourcing should consider regional regulatory landscapes, supply stability, and quality certifications.
Diversification of suppliers remains vital amid geopolitical and logistical uncertainties, ensuring continuity of supply for these critical antibiotics.

FAQs

1. Which suppliers are most reliable for Bacitracin Zinc?

Leading global suppliers like Sandoz and Chinese manufacturers such as Zhejiang Hisun provide reliable sources, provided they maintain GMP certification and consistent quality standards.

2. How has Chinese manufacturing impacted the global supply of Neomycin Sulfate?

Chinese firms dominate due to cost efficiencies, but regulatory scrutiny has increased, prompting supply chain diversification and quality improvements for international markets.

3. What are major factors influencing supply chain stability for Polymyxin B?

Production reliance on microbial fermentation, regulatory approvals, and geopolitical factors influence supply stability. The growth of certified Chinese manufacturers further impacts availability.

4. Are there alternative suppliers for these antibiotics outside China?

Yes. European and North American companies, such as Sandoz and Fresenius Kabi, supply these antibiotics, often sourcing from or manufacturing in compliance with stricter international standards.

5. What should buyers consider when sourcing these antibiotics?

Buyers should prioritize suppliers with GMP and GxP certifications, sufficient manufacturing capacity, consistent quality documentation, and a track record of regulatory compliance to ensure supply reliability.

Sources:

[1] Market Research Future, “Antibiotics Market Analysis.”
[2] Global Data Pharmaceutical Reports, “Active Pharmaceutical Ingredient Suppliers.”
[3] Chinese FDA and regional GMP certifications.
[4] Company Annual Reports and Official Websites.
[5] Industry Publications on Antibiotic Manufacturing and Supply Chains.

Suppliers and packagers for generic pharmaceutical drug: BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE